84 related articles for article (PubMed ID: 36564283)
1. Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].
Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2023 Jul; 34(7):631. PubMed ID: 36564283
[No Abstract] [Full Text] [Related]
2. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2020 Nov; 31(11):1476-1490. PubMed ID: 32861807
[No Abstract] [Full Text] [Related]
3. Corrigendum to 'Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712].
Heuser M; Ofran Y; Boissel N; Brunet Mauri S; Craddock C; Janssen J; Wierzbowska A; Buske C;
Ann Oncol; 2021 Jun; 32(6):821. PubMed ID: 33888380
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29].
Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;
Ann Oncol; 2023 Mar; 34(3):325. PubMed ID: 36529567
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 32 (2021) 439-451].
Baudin E; Caplin M; Garcia-Carbonero R; Fazio N; Ferolla P; Filosso PL; Frilling A; de Herder WW; Hörsch D; Knigge U; Korse CM; Lim E; Lombard-Bohas C; Pavel M; Scoazec JY; Sundin A; Berruti A;
Ann Oncol; 2021 Nov; 32(11):1453-1455. PubMed ID: 34598840
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255].
Vogel A; Cervantes A; Chau I; Daniele B; Llovet JM; Meyer T; Nault JC; Neumann U; Ricke J; Sangro B; Schirmacher P; Verslype C; Zech CJ; Arnold D; Martinelli E;
Ann Oncol; 2022 Jun; 33(6):666. PubMed ID: 35365377
[No Abstract] [Full Text] [Related]
7. Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022].
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Costes Martineau V; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2023 Oct; 8(5):101630. PubMed ID: 37625197
[No Abstract] [Full Text] [Related]
8. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv267. PubMed ID: 30188977
[No Abstract] [Full Text] [Related]
9. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv268-iv269. PubMed ID: 30285214
[No Abstract] [Full Text] [Related]
10. Erratum to "Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": Annals of Oncology 30; 2019: 1194-1220.
Cardoso F; Kyriakides S; Ohno S; Penault-Llorca F; Poortmans P; Rubio IT; Zackrisson S; Senkus E;
Ann Oncol; 2021 Feb; 32(2):284. PubMed ID: 32912619
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Sep; 33(9):988. PubMed ID: 35810138
[No Abstract] [Full Text] [Related]
12. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
[TBL] [Abstract][Full Text] [Related]
13. The ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guidelines for bone sarcomas - the challenges of the fight against rare cancers.
Andreou D
Ann Oncol; 2021 Dec; 32(12):1470-1471. PubMed ID: 34560241
[No Abstract] [Full Text] [Related]
14. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
[TBL] [Abstract][Full Text] [Related]
15. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Yoshino T; Arnold D; Taniguchi H; Pentheroudakis G; Yamazaki K; Xu RH; Kim TW; Ismail F; Tan IB; Yeh KH; Grothey A; Zhang S; Ahn JB; Mastura MY; Chong D; Chen LT; Kopetz S; Eguchi-Nakajima T; Ebi H; Ohtsu A; Cervantes A; Muro K; Tabernero J; Minami H; Ciardiello F; Douillard JY
Ann Oncol; 2018 Jan; 29(1):44-70. PubMed ID: 29155929
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Jan; 33(1):117. PubMed ID: 34857439
[No Abstract] [Full Text] [Related]
17. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
18. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
19. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
Zagouri F; Liakou P; Bartsch R; Peccatori FA; Tsigginou A; Dimitrakakis C; Zografos GC; Dimopoulos MA; Azim HA
Breast; 2015 Aug; 24(4):513-23. PubMed ID: 25818651
[TBL] [Abstract][Full Text] [Related]
20. Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?
Flynt KA; Dillman JR; Davenport MS; Smith EA; Else T; Strouse PJ; Caoili EM
Pediatr Radiol; 2015 Jul; 45(8):1160-8. PubMed ID: 25794486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
